CCR9–CCL25 interaction suppresses apoptosis of lung cancer cells by activating the PI3K/Akt pathway
作者： Baijun Li , Zhiwei Wang , Yonglong Zhong , Jiao Lan , Xiangwei Li
DOI: 10.1007/S12032-015-0531-0
关键词: Wortmannin 、 CCL25 、 Cancer research 、 Carcinogenesis 、 Biology 、 Protein kinase B 、 In vitro 、 Apoptosis 、 Cell culture 、 PI3K/AKT/mTOR pathway 、 Cell biology
摘要: … receptor-9 (CCR9) is … signals elicited by the interaction between CCR9 and its natural ligand CCL25 in NSCLC are unknown. Here, we selectively depleted CCR9 and inhibited CCR9–…
springer.com
sci-hub.se 参考文章(32)
Pranav Gupta, Praveen K. Sharma, Hina Mir, Rajesh Singh, Nalinaksha Singh, Goetz H. Kloecker, James W. Lillard, Shailesh Singh, CCR9/CCL25 expression in non-small cell lung cancer correlates with aggressive disease and mediates key steps of metastasis Oncotarget. ,vol. 5, pp. 10170- 10179 ,(2014) , 10.18632/ONCOTARGET.2526
Miguel Parra, Daniel Herrera, J Mauricio Calvo-Calle, Lawrence J Stern, Carlos A Parra-López, Eugene Butcher, Manuel Franco, Juana Angel, None, Circulating human rotavirus specific CD4 T cells identified with a class II tetramer express the intestinal homing receptors α4β7 and CCR9 Virology. ,vol. 452, pp. 191- 201 ,(2014) , 10.1016/J.VIROL.2014.01.014
Tieluo Li, Ahmet Kilic, Xufeng Wei, Changfu Wu, Gary Schwartzbauer, G. Kwame Yankey, Christopher DeFilippi, Meredith Bond, Zhongjun J. Wu, Bartley P. Griffith, Regional imbalanced activation of the calcineurin/BAD apoptotic pathway and the PI3K/Akt survival pathway after myocardial infarction International Journal of Cardiology. ,vol. 166, pp. 158- 165 ,(2013) , 10.1016/J.IJCARD.2011.10.107
Claudia Fumarola, Mara A. Bonelli, Pier Giorgio Petronini, Roberta R. Alfieri, Targeting PI3K/AKT/mTOR pathway in non small cell lung cancer. Biochemical Pharmacology. ,vol. 90, pp. 197- 207 ,(2014) , 10.1016/J.BCP.2014.05.011
Florent Ginhoux, Anne B. Krug, Andreas Schlitzer, Alexander F. Heiseke, Henrik Einwächter, Wolfgang Reindl, Matthias Schiemann, Calin-Petru Manta, Peter See, Jan-Hendrik Niess, Tobias Suter, Tissue-specific differentiation of a circulating CCR9- pDC-like common dendritic cell precursor. Blood. ,vol. 119, pp. 6063- 6071 ,(2012) , 10.1182/BLOOD-2012-03-418400
William Rostène, De nouvelles perspectives pour les chimiokines Biologie Aujourd'hui. ,vol. 204, pp. 267- 272 ,(2010) , 10.1051/JBIO/2010020
Sonia Chamorro, Maria Vela, Ana Franco-Villanueva, Laura Carramolino, Julio Gutiérrez, Lucio Gómez, María Lozano, Beatriz Salvador, Mónica García-Gallo, Carlos Martínez-A, Leonor Kremer, Antitumor effects of a monoclonal antibody to human CCR9 in leukemia cell xenografts. mAbs. ,vol. 6, pp. 1000- 1012 ,(2014) , 10.4161/MABS.29063
Hasmeena Kathuria, Yaron Gesthalter, Avrum Spira, Jerome Brody, Katrina Steiling, Updates and Controversies in the Rapidly Evolving Field of Lung Cancer Screening, Early Detection, and Chemoprevention Cancers. ,vol. 6, pp. 1157- 1179 ,(2014) , 10.3390/CANCERS6021157
SHU-FEN PENG, CHAO-YING LEE, MANN-JEN HOUR, SHIH-CHANG TSAI, DAIH-HUANG KUO, FU-AN CHEN, PO-CHUEN SHIEH, JAI-SING YANG, Curcumin-loaded nanoparticles enhance apoptotic cell death of U2OS human osteosarcoma cells through the Akt-Bad signaling pathway. International Journal of Oncology. ,vol. 44, pp. 238- 246 ,(2014) , 10.3892/IJO.2013.2175
Jen-Chung Ko, Hsien-Chun Chiu, Jhan-Jhang Syu, Chien-Yu Chen, Yun-Ting Jian, Yi-Jhen Huang, Ting-Yu Wo, Yi-Jun Jian, Po-Yuan Chang, Tai-Jing Wang, Yun-Wei Lin, Down-regulation of MSH2 expression by Hsp90 inhibition enhances cytotoxicity affected by tamoxifen in human lung cancer cells. Biochemical and Biophysical Research Communications. ,vol. 456, pp. 506- 512 ,(2015) , 10.1016/J.BBRC.2014.11.116